nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—Atorvastatin—HMGCR—metabolic syndrome X	0.098	1	CrCbGaD
Conivaptan—CYP3A4—Liver X Receptor Pathway—NR1H3—metabolic syndrome X	0.0369	0.0409	CbGpPWpGaD
Conivaptan—AVPR2—Arf6 trafficking events—SLC2A4—metabolic syndrome X	0.0351	0.0389	CbGpPWpGaD
Conivaptan—CYP3A4—Liver X Receptor Pathway—SCD—metabolic syndrome X	0.0326	0.0362	CbGpPWpGaD
Conivaptan—CYP3A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.0221	0.0245	CbGpPWpGaD
Conivaptan—AVPR2—Arf6 trafficking events—INS—metabolic syndrome X	0.0197	0.0219	CbGpPWpGaD
Conivaptan—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.0177	0.0196	CbGpPWpGaD
Conivaptan—CYP3A4—Liver X Receptor Pathway—SREBF1—metabolic syndrome X	0.0164	0.0182	CbGpPWpGaD
Conivaptan—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.0162	0.0179	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.0139	0.0154	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—HTR2C—metabolic syndrome X	0.0135	0.015	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.0134	0.0148	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.0133	0.0147	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—GHRL—metabolic syndrome X	0.0128	0.0142	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—GHRL—metabolic syndrome X	0.0126	0.014	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—GHRL—metabolic syndrome X	0.0125	0.0139	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—metabolic syndrome X	0.0121	0.0134	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.0115	0.0127	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.0114	0.0127	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.0114	0.0126	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.0107	0.0119	CbGpPWpGaD
Conivaptan—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.0107	0.0118	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.0104	0.0116	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.0104	0.0115	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.0102	0.0113	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00937	0.0104	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.0093	0.0103	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.00929	0.0103	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL5—metabolic syndrome X	0.00927	0.0103	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL5—metabolic syndrome X	0.00921	0.0102	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00894	0.00991	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00888	0.00984	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00874	0.00969	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00868	0.00962	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00847	0.0094	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00841	0.00933	CbGpPWpGaD
Conivaptan—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.00823	0.00912	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00803	0.0089	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00797	0.00883	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—AGT—metabolic syndrome X	0.00786	0.00871	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—AGT—metabolic syndrome X	0.00776	0.0086	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00774	0.00858	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—AGT—metabolic syndrome X	0.0077	0.00854	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	0.00734	0.00814	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.00703	0.00779	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00681	0.00755	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00676	0.00749	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—GHRL—metabolic syndrome X	0.00645	0.00716	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—GHRL—metabolic syndrome X	0.00641	0.0071	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—CCL2—metabolic syndrome X	0.00639	0.00708	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—CCL2—metabolic syndrome X	0.00634	0.00703	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00622	0.0069	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00618	0.00685	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CNR1—metabolic syndrome X	0.00611	0.00678	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CNR1—metabolic syndrome X	0.00607	0.00673	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—GCK—metabolic syndrome X	0.00583	0.00647	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—CETP—metabolic syndrome X	0.00563	0.00624	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00533	0.00591	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.0052	0.00577	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00517	0.00573	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00494	0.00547	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.0049	0.00544	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCL5—metabolic syndrome X	0.00474	0.00525	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL5—metabolic syndrome X	0.0047	0.00521	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.00454	0.00503	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00448	0.00497	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00445	0.00494	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00429	0.00475	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00425	0.00472	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.00411	0.00456	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00405	0.00449	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—AGT—metabolic syndrome X	0.00396	0.00439	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—AGT—metabolic syndrome X	0.00393	0.00436	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00385	0.00427	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00382	0.00423	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.00373	0.00413	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.0037	0.0041	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00365	0.00404	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00362	0.00401	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00361	0.004	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00349	0.00387	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00347	0.00385	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00345	0.00383	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00343	0.0038	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GHRL—metabolic syndrome X	0.00331	0.00367	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GHRL—metabolic syndrome X	0.00329	0.00365	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CCL2—metabolic syndrome X	0.00326	0.00362	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CCL2—metabolic syndrome X	0.00324	0.00359	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	0.00314	0.00349	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CNR1—metabolic syndrome X	0.00314	0.00348	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CNR1—metabolic syndrome X	0.00311	0.00345	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00306	0.00339	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HDAC3—metabolic syndrome X	0.00296	0.00329	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	0.00295	0.00327	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HDAC3—metabolic syndrome X	0.00294	0.00326	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00268	0.00297	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00266	0.00295	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00265	0.00294	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00263	0.00292	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RBP4—metabolic syndrome X	0.00258	0.00286	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TRIB3—metabolic syndrome X	0.00258	0.00286	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.00257	0.00285	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RBP4—metabolic syndrome X	0.00256	0.00284	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TRIB3—metabolic syndrome X	0.00256	0.00284	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL5—metabolic syndrome X	0.00243	0.0027	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00242	0.00268	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL5—metabolic syndrome X	0.00241	0.00268	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.0024	0.00267	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	0.00234	0.00259	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOC3—metabolic syndrome X	0.00229	0.00254	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOC3—metabolic syndrome X	0.00227	0.00252	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AGT—metabolic syndrome X	0.00224	0.00248	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AGT—metabolic syndrome X	0.00222	0.00246	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.00206	0.00229	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2C—metabolic syndrome X	0.00205	0.00227	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AGT—metabolic syndrome X	0.00203	0.00225	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AGT—metabolic syndrome X	0.00202	0.00224	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CYBA—metabolic syndrome X	0.002	0.00222	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CYBA—metabolic syndrome X	0.00198	0.0022	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GHRL—metabolic syndrome X	0.00196	0.00217	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GHRL—metabolic syndrome X	0.00194	0.00215	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CNR1—metabolic syndrome X	0.00185	0.00205	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CNR1—metabolic syndrome X	0.00184	0.00204	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL2—metabolic syndrome X	0.00167	0.00186	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL2—metabolic syndrome X	0.00166	0.00184	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF2—metabolic syndrome X	0.00151	0.00168	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF2—metabolic syndrome X	0.0015	0.00167	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOB—metabolic syndrome X	0.00147	0.00163	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOB—metabolic syndrome X	0.00146	0.00162	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL5—metabolic syndrome X	0.00144	0.00159	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00143	0.00159	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL5—metabolic syndrome X	0.00143	0.00158	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00142	0.00157	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.00141	0.00157	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LPL—metabolic syndrome X	0.0014	0.00156	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LPL—metabolic syndrome X	0.00139	0.00155	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGT—metabolic syndrome X	0.0012	0.00133	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGT—metabolic syndrome X	0.00119	0.00132	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—metabolic syndrome X	0.00118	0.0013	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOE—metabolic syndrome X	0.00118	0.0013	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—metabolic syndrome X	0.00117	0.0013	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOE—metabolic syndrome X	0.00117	0.0013	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—APOA1—metabolic syndrome X	0.00116	0.00129	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—APOA1—metabolic syndrome X	0.00116	0.00128	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IRS1—metabolic syndrome X	0.00105	0.00116	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IRS1—metabolic syndrome X	0.00104	0.00116	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—INS—metabolic syndrome X	0.00101	0.00111	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—INS—metabolic syndrome X	0.000998	0.00111	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—metabolic syndrome X	0.000989	0.0011	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—metabolic syndrome X	0.000982	0.00109	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—metabolic syndrome X	0.000973	0.00108	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—metabolic syndrome X	0.000966	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000924	0.00102	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000917	0.00102	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—metabolic syndrome X	0.000882	0.000978	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—metabolic syndrome X	0.000875	0.000971	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000756	0.000838	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT1—metabolic syndrome X	0.00075	0.000832	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—metabolic syndrome X	0.000744	0.000825	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—metabolic syndrome X	0.000738	0.000819	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000703	0.000779	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000686	0.000761	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT1—metabolic syndrome X	0.000681	0.000755	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000626	0.000694	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000626	0.000694	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000589	0.000653	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000583	0.000646	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—metabolic syndrome X	0.000579	0.000642	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.000501	0.000555	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	0.000475	0.000526	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—metabolic syndrome X	0.000439	0.000487	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—metabolic syndrome X	0.000436	0.000484	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—G6PD—metabolic syndrome X	0.000423	0.000469	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	0.000413	0.000458	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT1—metabolic syndrome X	0.000405	0.000449	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPA—metabolic syndrome X	0.000404	0.000447	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCKR—metabolic syndrome X	0.000404	0.000447	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT1—metabolic syndrome X	0.000402	0.000446	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	0.000391	0.000433	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA5—metabolic syndrome X	0.000387	0.000429	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	0.00036	0.000399	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	0.000323	0.000358	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LIPC—metabolic syndrome X	0.000321	0.000355	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GCK—metabolic syndrome X	0.000321	0.000355	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOC3—metabolic syndrome X	0.000319	0.000353	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CETP—metabolic syndrome X	0.000309	0.000343	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	0.000296	0.000328	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	0.000288	0.000319	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GOT2—metabolic syndrome X	0.00028	0.00031	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	0.00028	0.00031	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	0.000249	0.000276	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	0.000249	0.000276	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GGT1—metabolic syndrome X	0.000241	0.000268	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GOT1—metabolic syndrome X	0.000241	0.000268	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOB—metabolic syndrome X	0.000205	0.000227	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	0.000199	0.000221	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPL—metabolic syndrome X	0.000196	0.000217	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CD36—metabolic syndrome X	0.000186	0.000206	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARA—metabolic syndrome X	0.000173	0.000192	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AGT—metabolic syndrome X	0.000167	0.000186	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOE—metabolic syndrome X	0.000164	0.000182	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—APOA1—metabolic syndrome X	0.000162	0.00018	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—metabolic syndrome X	0.000143	0.000158	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INS—metabolic syndrome X	0.00014	0.000155	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—metabolic syndrome X	0.000128	0.000142	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—metabolic syndrome X	0.000123	0.000136	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	0.000112	0.000125	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKT1—metabolic syndrome X	5.65e-05	6.26e-05	CbGpPWpGaD
